Volume 22, Number 8—August 2016
Research
Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014
Table 2
Illness at any time during preceding month | |||
---|---|---|---|
Sought medical care | 13 (72) | 4 (10) | 6.4 (2.7–15.2) |
Admitted to hospital | 11 (61) | 0 (0) | 6.9 (3.5–13.6) |
Fever | 13 (72) | 3 (7) | 7.0 (3.0–16.5) |
Cough | 12 (67) | 5 (23) | 4.9 (2.2–11.0) |
Shortness of breath | 8 (44) | 1 (2) | 4.4 (2.4–8.1) |
Diarrhea | 8 (47)‡ | 3 (8)§ | 3.7 (1.9–7.4) |
Vomiting | 2 (12)‡ | 1 (3)§ | 2.4 (1.0–6.0) |
Chills | 5 (29)‡ | 1 (3)§ | 3.5 (1.9–6.5) |
Body aches | 9 (53)‡ | 1 (3)§ | 5.3 (2.7–10.3) |
*Bold indicates statistical significance. Analysis includes all relatives 14 y of age tested for MERS-CoV (n = 59), regardless of household or visitor status. Positive indicates positive rRT-PCR or serologic antibody testing for MERS-CoV; negative indicates negative rRT-PCR and serologic antibody testing. Children (one 2-year-old rRT-PCR–positive child and 19 rRT-PCR–negative children) were excluded because they did not have serologic antibody testing. Listed chronic medical problems were self-reported; no one reported chronic lung or kidney disease, and other self-reported problems (hyperthyroidism, allergies, and solitary kidney) were excluded. MERS-CoV, Middle East respiratory syndrome coronavirus; rRT-PCR, real-time reverse transcription PCR.
†Ages were as follows: MERS-CoV positive: median 37 y (range 16–73 y); MERS-CoV-negative: median 25 y (range 14–60y).
‡Of the 17 persons for whom this information was reported.
§Of the 40 persons for whom this information was reported.